Search research articles
Contact Us
Filters
Showing results (441-450 of 487) with videos related to
Page
of 49
Sort By:
JAMA Network Open
|
November 6, 2023
Guideline-Based Follow-Up Outcomes in Patients With Gastrointestinal Stromal Tumor With Low Risk of Recurrence: A Report From the Italian Sarcoma Group
Lorenzo D'Ambrosio, Elena Fumagalli, Tommaso Martino De Pas, et al.
The Lancet. Oncology
|
May 14, 2017
Histotype-tailored neoadjuvant chemotherapy versus standard chemotherapy in patients with high-risk soft-tissue sarcomas (ISG-STS 1001): an international, open-label, randomised, controlled, phase 3, multicentre trial
Alessandro Gronchi, Stefano Ferrari, Vittorio Quagliuolo, et al.
Annals of Surgical Oncology
|
June 11, 2026
Predicting Failure of Active Surveillance in Desmoid-Type Fibromatosis Using Radiomics: An International Multi-center Cohort Study
Stefanie N Hakkesteegt, Douwe J Spaanderman, Chiara Colombo, et al.
Molecular Cancer Research : MCR
|
January 29, 2017
Genome-Wide Analysis Identifies MEN1 and MAX Mutations and a Neuroendocrine-Like Molecular Heterogeneity in Quadruple WT GIST
Maria A Pantaleo, Milena Urbini, Valentina Indio, et al.
Cancer
|
August 16, 2020
Patterns of recurrence and survival probability after second recurrence of retroperitoneal sarcoma: A study from TARPSWG
Winan J van Houdt, Marco Fiore, Francesco Barretta, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 17, 2024
Neoadjuvant Chemotherapy in High-Grade Myxoid Liposarcoma: Results of the Expanded Cohort of a Randomized Trial From Italian (ISG), Spanish (GEIS), French (FSG), and Polish Sarcoma Groups (PSG)
Alessandro Gronchi, Emanuela Palmerini, Vittorio Quagliuolo, et al.
Annals of Surgery
|
December 22, 2025
Accuracy of Histology and Malignancy Grade between Preoperative Biopsy and Surgical Specimens in Primary Retroperitoneal Sarcoma. A Study from the Prospective Retroperitoneal Sarcoma Registry (Resar)
Alessandra Borghi, Marco Fiore, Gabriele Tiné, et al.
Eclinicalmedicine
|
March 5, 2026
Neoadjuvant radiotherapy for primary retroperitoneal well-differentiated liposarcoma: a Transatlantic Australasian Retroperitoneal Sarcoma Working Group (TARPSWG) propensity score matched analysis
Mark Fairweather, Megan Sulciner, Joshua S Jolissaint, et al.
Cancer
|
October 13, 2021
Neoadjuvant chemotherapy in high-risk soft tissue sarcomas: A Sarculator-based risk stratification analysis of the ISG-STS 1001 randomized trial
Sandro Pasquali, Emanuela Palmerini, Vittorio Quagliuolo, et al.
Critical Reviews in Oncology/Hematology
|
June 27, 2026
Corrigendum to "Management of atypical cartilaginous tumors (ACT): An Italian Sarcoma Group (ISG) consensus document" [Crit. Rev. Oncol. Hematol. 223 (2026) 105358]
Domenico Andrea Campanacci, Giacomo Giulio Bald, Roberto Scanferla, et al.
Page
of 49
Search research articles
Search
Showing results (441-450 of 487) with videos related to
Sort By:
Page
of 49
JAMA Network Open
|
November 6, 2023
Guideline-Based Follow-Up Outcomes in Patients With Gastrointestinal Stromal Tumor With Low Risk of Recurrence: A Report From the Italian Sarcoma Group
Lorenzo D'Ambrosio, Elena Fumagalli, Tommaso Martino De Pas, et al.
The Lancet. Oncology
|
May 14, 2017
Histotype-tailored neoadjuvant chemotherapy versus standard chemotherapy in patients with high-risk soft-tissue sarcomas (ISG-STS 1001): an international, open-label, randomised, controlled, phase 3, multicentre trial
Alessandro Gronchi, Stefano Ferrari, Vittorio Quagliuolo, et al.
Annals of Surgical Oncology
|
June 11, 2026
Predicting Failure of Active Surveillance in Desmoid-Type Fibromatosis Using Radiomics: An International Multi-center Cohort Study
Stefanie N Hakkesteegt, Douwe J Spaanderman, Chiara Colombo, et al.
Molecular Cancer Research : MCR
|
January 29, 2017
Genome-Wide Analysis Identifies MEN1 and MAX Mutations and a Neuroendocrine-Like Molecular Heterogeneity in Quadruple WT GIST
Maria A Pantaleo, Milena Urbini, Valentina Indio, et al.
Cancer
|
August 16, 2020
Patterns of recurrence and survival probability after second recurrence of retroperitoneal sarcoma: A study from TARPSWG
Winan J van Houdt, Marco Fiore, Francesco Barretta, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 17, 2024
Neoadjuvant Chemotherapy in High-Grade Myxoid Liposarcoma: Results of the Expanded Cohort of a Randomized Trial From Italian (ISG), Spanish (GEIS), French (FSG), and Polish Sarcoma Groups (PSG)
Alessandro Gronchi, Emanuela Palmerini, Vittorio Quagliuolo, et al.
Annals of Surgery
|
December 22, 2025
Accuracy of Histology and Malignancy Grade between Preoperative Biopsy and Surgical Specimens in Primary Retroperitoneal Sarcoma. A Study from the Prospective Retroperitoneal Sarcoma Registry (Resar)
Alessandra Borghi, Marco Fiore, Gabriele Tiné, et al.
Eclinicalmedicine
|
March 5, 2026
Neoadjuvant radiotherapy for primary retroperitoneal well-differentiated liposarcoma: a Transatlantic Australasian Retroperitoneal Sarcoma Working Group (TARPSWG) propensity score matched analysis
Mark Fairweather, Megan Sulciner, Joshua S Jolissaint, et al.
Cancer
|
October 13, 2021
Neoadjuvant chemotherapy in high-risk soft tissue sarcomas: A Sarculator-based risk stratification analysis of the ISG-STS 1001 randomized trial
Sandro Pasquali, Emanuela Palmerini, Vittorio Quagliuolo, et al.
Critical Reviews in Oncology/Hematology
|
June 27, 2026
Corrigendum to "Management of atypical cartilaginous tumors (ACT): An Italian Sarcoma Group (ISG) consensus document" [Crit. Rev. Oncol. Hematol. 223 (2026) 105358]
Domenico Andrea Campanacci, Giacomo Giulio Bald, Roberto Scanferla, et al.
Page
of 49